Approval · Notice of Compliance 13905 · 2012
VITAROS: Notice of Compliance 13905
Issued November 27, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13905
- Date
- November 27, 2012
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Extension of shelf life of the 300 mcg/100 mg strength when stoored under refirigeration; updateds to the PROduct Monograph
- Therapeutic class
- Treatment of male erectile dysfuntction
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VITAROS | Not yet assigned | — |
Medicinal ingredients
- ALPROSTADIL 330 MCG per 100MG
- ALPROSTADIL 220 MCG per 100MG